+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 56 Pages
  • Global
From
Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Post Operative Nausea And Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 38 Pages
  • Global
From
Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 37 Pages
  • Global
From
Vasopressin V1a Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Vasopressin V1a Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 44 Pages
  • Global
From
Vasopressin V2 Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Vasopressin V2 Receptor Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 45 Pages
  • Global
From
Potassium Transporting ATPase Alpha Chain 1 (Gastric H-K ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Potassium Transporting ATPase Alpha Chain 1 (Gastric H-K ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 57 Pages
  • Global
From
Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 58 Pages
  • Global
From
Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 50 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 632 Pages
  • Global
From
Diabetic Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 37 Pages
  • Global
From
Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • Global
From
Northern America - Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Northern America - Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • North America
From
EU - Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

EU - Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • Europe
From
Eastern Europe - Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact - Product Thumbnail Image

Eastern Europe - Aluminium Hydroxide - Market Analysis, Forecast, Size, Trends and Insights. Update: COVID-19 Impact

  • Report
  • April 2025
  • Europe
From
D-glucitol (Sorbitol): European Union Market Outlook 2023-2027 - Product Thumbnail Image

D-glucitol (Sorbitol): European Union Market Outlook 2023-2027

  • Report
  • April 2025
  • 20 Pages
  • Europe
From
D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • Global
From
Sorbitol (Excluding D-Glucitol) - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

Sorbitol (Excluding D-Glucitol) - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • Global
From
China - D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

China - D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • China
From
U.S. - D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

U.S. - D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • United States
From
United Kingdom - D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights - Product Thumbnail Image

United Kingdom - D-Glucitol (Sorbitol) - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • May 2025
  • United Kingdom
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more